AtherosclerosisHumansLupus ErythematosusSystemicFemaleMale
Assessment of the 2025 EAS clinical staging system for cardiometabolic disorders in systemic lupus erythematosus.
Lévi-Dan Azoulay, Nadjia Kachenoura, Samia Boussouar, Etienne Charpentier, Nicoletta Pasi, Lan-Anh Nguyen, Nassim Ait Abdallah, Micheline Pha, Miguel Hié, Alexis Mathian, Matthias Papo, Fleur Cohen-Aubart, Julien Haroche, Zahir Amoura, Alban Redheuil
Published: 202510.1016/j.atherosclerosis.2025.120562
Abstract
BACKGROUND AND AIMS: Systemic lupus erythematosus (SLE) is an autoimmune disease associated with an increased risk of atherosclerotic cardiovascular disease (ASCVD). However, risk stratification remains an unmet need. In 2025, the European Atheroscle…
Preview only. Read the full abstract at the source